Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

[This corrects the article DOI: 10.3389/fcvm.2023.1142721.].

Saved in:

Bibliographic Details
Published in:	Frontiers in cardiovascular medicine Vol. 11; p. 1371699
Main Authors:	Wang, An, Chen, Mengqi, Zhuang, Qi, Guan, Lihua, Xie, Weiping, Wang, Lan, Huang, Wei, Cheng, Zhaozhong, Yu, Shiyong, Zhou, Hongmei, Shen, Jieyan
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 21-02-2024
Subjects:	6-min walk distance Cardiovascular Medicine efficacy pulmonary arterial hypertension risk stratification time to clinical improvement time to clinical improvement risk stratification 6-min walk distance pulmonary arterial hypertension efficacy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[This corrects the article DOI: 10.3389/fcvm.2023.1142721.].
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correction/Retraction-1 These authors have contributed equally to this work Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
ISSN:	2297-055X 2297-055X
DOI:	10.3389/fcvm.2024.1371699